<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03543553</url>
  </required_header>
  <id_info>
    <org_study_id>ecoval</org_study_id>
    <nct_id>NCT03543553</nct_id>
  </id_info>
  <brief_title>From Brain Currents to Interpersonal Flow: Investigating the Social Processing Stream of Schizophrenia</brief_title>
  <acronym>ecoval</acronym>
  <official_title>From Brain Currents to Interpersonal Flow: Investigating the Social Processing Stream of Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this project is to identify the neural signature of the impaired
      ability to relate socially seen in individuals with schizophrenia. A hypothesized path from
      the neural processes of social cognition, to social cognition assessed behaviorally, to
      real-life social interactions is examined. Secondary aims are to compare electrophysiological
      measures of high vs low level social cognition; to develop assessment methods of real-life
      behavior; and to increase the ecological validity of schizophrenia research. Much research
      within the field is devoid of personal meaning and interpersonal context. This project's use
      of personalized assessment allows for an ecologically valid approach to the social deficits
      of schizophrenia.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Neurophysiology: EEG</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>EEG mu suppression paradigm using point-light displays</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurophysiology: ERP</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>ERP mentalizing paradigm (perspective taking)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognition</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>Matrics Consensus Cognitive Battery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Negative symptoms: clinician-rated</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>Positive and Negative Syndrome Scale (PANSS) 2. Objectively assessed using computerized software (FaceReader, PRAAT) of video-taped personal narratives produced by the participants</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Negative symptoms: objective 1</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>FaceReader</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Negative symptoms: objective 2</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>PRAAT</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social cognition: complex ToM</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>Movie for the Assessment of Social Cognition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social cognition: low level ToM</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>The Hinting Task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social cognition: facial emotion perception</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>Pictures of Facial Affect</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social cognition: body language reading</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>Emotion in Biological Motion test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functioning</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>Social Functioning Scale (SFS). Seven scales that can be combined into a total score. Mean score in a schizophrenia population = 100, SD = 15. For both the seven scales and the total score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Real-world behaviour</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>Day Reconstruction Method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Real-world social interactions</measure>
    <time_frame>1 day (when assessed)</time_frame>
    <description>Video-ethnography</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Cognitive Impairment</condition>
  <condition>Social Competence</condition>
  <arm_group>
    <arm_group_label>SZ</arm_group_label>
    <description>Individuals with a diagnosis of schizophrenia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HC</arm_group_label>
    <description>Healthy control participants</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>This is not an intervention study</intervention_name>
    <description>This is not an intervention study</description>
    <arm_group_label>HC</arm_group_label>
    <arm_group_label>SZ</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals with a diagnosis of schizophrenia will be compared to healthy control
        participants
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  schizophrenia

          -  schizoaffective disorder

        Exclusion Criteria

          -  diabetes

          -  Hyperthyroidism

          -  severe head trauma

          -  neurological disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>April 17, 2018</study_first_submitted>
  <study_first_submitted_qc>May 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2018</study_first_posted>
  <last_update_submitted>March 12, 2019</last_update_submitted>
  <last_update_submitted_qc>March 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Anja Vaskinn</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

